Team Group: Senior Consultant

Cheryl A. Fragiadakis headed Technology Transfer and Intellectual Property Management at the Lawrence Berkeley National Laboratory, which is operated for the Department of Energy by the University of California. Berkeley Lab conducts unclassified research and development in multiple disciplines including chemistry, biology, physics, materials, engineering and computer science. Technology Transfer is responsible for industrial collaborations, patents, copyrights, licensing, marketing and business development. Under her leadership, LBNL licensed technologies resulting in over 40 start-up companies with a 95% five year success record, and has managed over a hundred research collaborations between private companies and the Berkeley Lab. Before joining LBNL, she spent over 10 years working in the private sector for a major oil company. Ms. Fragiadakis has a B.S. in Chemical Engineering from the Colorado School of Mines, and an MBA from the U.C. Berkeley Haas School of Business.

Dr. David Glass is an independent consultant with over thirty years’ experience in biotechnology and related life sciences fields, with much of that time devoted to patents, licensing and technology transfer. David began his career at BioTechnica International, where he created and managed the company’s programs for intellectual property protection and agricultural biotechnology regulatory affairs. He has served as associate director of the tech transfer office at Massachusetts General Hospital, and has also managed technology transfer as a consultant or part-time employee at several other academic institutions including McLean Hospital, Joslin Diabetes Center, and Baystate Medical Center. David has also consulted for several other academic institutions and life sciences companies on various aspects of technology licensing and academic-industry partnering. Since 2014, he has managed tech transfer as a consultant at the University of Massachusetts at Dartmouth, while carrying out other consulting projects within the UMass system. David also maintains an active consulting practice helping biofuel and industrial biotechnology companies manage government regulations, and during his career he has written and published numerous market reports and other publications on various topics in agricultural, environmental and industrial biotechnology. He is a longstanding member of LES and AUTM, and was awarded the Certified Licensing Professional certification in July 2008 (recertified July 2011, expired June 2014) and the Registered Technology Transfer Professional certification in November 2013 (active). He holds a B.S. from Cornell University and a Ph.D. from Princeton University. David has particular expertise in biotechnology, medical devices, agriculture, environmental remediation technologies, and renewable fuels.

Jack Pincus has held senior management positions in the life sciences industry and has expertise in technology commercialization, business development, licensing, and intellectual property management. He has over 35 years’ experience in concept evaluation, market and intellectual property assessment, licensing, strategic alliance formation, start-up formation, and R&D management. Jack is currently an independent consultant providing services in all of these areas. He was previously vice president of technology transfer at Indiana University Research and Technology Corporation where he oversaw the full spectrum of technology transfer activities from concept evaluation to licensing and start-up formation. Before that he was Vice President for Business Development at MBI International, a biotechnology corporation devoted to maturing early stage products and processes, Director of Marketing at Applied DNA Systems, a startup biotechnology company, Director of Research and Development at Becton Dickinson Immunodiagnostics, a manufacturer of clinical diagnostic products, and Associate Director of the Biomedical Research Laboratory at SRI International, a major contract research and consulting firm. Earlier in his career he managed biomedical research programs at the US National Institutes of Health and the Massachusetts General Hospital. Jack holds an A.B. in biology and chemistry from New York University and a Ph.D. in biochemistry from Columbia University.

Keeley’s previous work includes serving at Quintiles’ consulting practice in the Market Intelligence Group. Her role as Senior Market Analyst was to collect and analyze qualitative and quantitative market data to inform business decisions for clients in the healthcare and pharmaceuticals industries. Keeley’s specialization includes understanding international reimbursement and regulatory approval pathways as well as business drivers for pharmaceuticals and companion diagnostics. She has experience moderating interviews with budget, laboratory, and clinical stakeholders. Before Quintiles, Keeley worked at the Technology Transfer Office of Boston Children’s Hospital where she provided market knowledge to aid in commercialization of the portfolio of innovations, especially healthcare IT, developed by researchers. She collected market data to represent the potential of novel technologies and inform licensing executives negotiating with potential partners, including Pharma and Biotech, Diagnostics Companies, Payers, Healthcare IT companies, and Venture Capitalists.

Dr. Al Poskanzer is a seasoned professional with a combination of business & academic qualifications and experience spanning 40 years that is truly unique. With a Ph.D. in physical chemistry from Clarkson University, Al has 11 years successful industrial R&D experience, including eight years as research group leader and research manager at the Dynachem Division of Morton-Thiokol. During that time, Al & his team developed over 60 new chemical products for the printed circuit and microelectronics industries, several of which set the industry standard. Al then spent 7 years in industrial sales & marketing, including as chief operating officer of a small startup company producing and selling products he developed. Al is a technologist with 25 years experience assessing and evaluating new technologies as a technology assessment consultant. He has spent eleven years in academia managing a broad portfolio of technologies, negotiating and closing complex licensing deals. With technology licensing experience at the University of California and Arizona State University, Al directed the licensing office at Arizona State University, now the largest University in the US. He has licensed patented technologies ranging from rechargeable lithium battery technology to anti-cancer pharmaceuticals. Under his watch, ASU became 10th in the nation for new inventions disclosed by the faculty and 7th in the nation for new company startups. Al most recently served as Director, Technology Licensing at Boeing where he licensed important composite molding and drilling technologies for a broad variety of Boeing products including the C-17, the F-22 and Boeing’s new 787 Dreamliner. Following his tenure at Boeing, Al has been uniquely successful in pursuing his own private practice as a consultant in technology transfer & commercialization. Al has authored over 120 papers and publications in the specialty chemicals industry and is the recipient of the coveted “Gold Medal Award” from the American Electroplaters Society. Al is also the recipient of the 1999 Chairman’s Award from the Arizona Governor’s Strategic Partnership for Economic Development for his contributions in creating and implementing the Intellectual Property Policy of the Arizona Board of Regents, one of the most progressive in the nation. Al is a certified licensing professional (CLP) and is an active member of the Licensing Executives Society (LES) as well as the Association of University Technology Managers (AUTM).